ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib
Drug firm Eli Lilly said it has signed a voluntary licensing agreement with Natco Pharma to further expedite the availability of baricitinib for Covid-19 patients in India
Announcement as on 17 May 2021

Eli Lilly buckles under pressure, offers voluntary licence to Natco Pharma
Lily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy's, Lupin, Torrent Pharma and MSN Labs. Barcitinib, in combination with Remdesivir, received emergency approval last year f
Announcement as on 17 May 2021

Natco Pharma gains 4% on emergency use approval for Covid-19 medicine
The company has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India
Announcement as on 03 May 2021

Natco Pharma rallies 7% as firm seeks nod for Covid medicine Molnupiravir
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of Covid-19 replication
Announcement as on 26 April 2021

Stock market update: MidCap stocks advance; Natco Pharma leaps 7%
The S&P BSE MidCap index was trading 0.58 per cent up at 20773.57.
Announcement as on 08 April 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 789.55
  • 12Day Average: 788.68
  • 20Day Average: 801.68
  • 50Day Average: 831.01
  • 100Day Average: 874.7
  • 150Day Average: 943.99
  • 200Day Average: 931.32

524816 Indicators & signals

Indicator MACD (12,26,9)

792.78, 806.12, -14.51
Indicator MACD is in negative zone

Indicator ADX (14)

20.75, 11.83, 18.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 782.50 780.00 to 801.15 -0.67% 0.73 times
29 Thu Oct 2026 787.75 786.00 to 799.15 -0.71% 0.66 times
28 Wed Oct 2026 793.35 779.95 to 801.85 -0.09% 2.83 times
27 Tue Oct 2026 794.05 784.65 to 798.00 0.5% 0.45 times
26 Mon Oct 2026 790.10 782.85 to 796.15 -0.27% 0.63 times
23 Fri Oct 2026 792.20 778.00 to 796.70 0.85% 1.25 times
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 0.99 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.55 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 1.78 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.25 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top